关注
Leonard Lothstein
Leonard Lothstein
University of Tennessee Health Science Center
在 uthsc.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Taxol: Mechanisms of Action and Resistance a
SB Horwitz, L Lothstein, JJ Manfredi, W Mellado, J Parness, SN Roy, ...
Annals of the New York Academy of Sciences 466 (1), 733-744, 1986
2811986
Differential overexpression of three mdr gene family members in multidrug-resistant J774. 2 mouse cells. Evidence that distinct P-glycoprotein precursors are encoded by unique …
SI Hsu, L Lothstein, SB Horwitz
Journal of Biological Chemistry 264 (20), 12053-12062, 1989
2771989
ATM and the catalytic subunit of DNA-dependent protein kinase activate NF-κB through a common MEK/extracellular signal-regulated kinase/p90rsk signaling pathway in response to …
GR Panta, S Kaur, LG Cavin, ML Cortés, F Mercurio, L Lothstein, ...
Molecular and Cellular Biology 24 (5), 1823-1835, 2004
1692004
Structural analysis of the mouse mdr1a (P-glycoprotein) promoter reveals the basis for differential transcript heterogeneity in multidrug-resistant J774. 2 cells.
SI Hsu, D Cohen, LS Kirschner, L Lothstein, M Hartstein, SB Horwitz
Molecular and Cellular Biology 10 (7), 3596-3606, 1990
1571990
Distinct P-glycoprotein precursors are overproduced in independently isolated drug-resistant cell lines
LM Greenberger, L Lothstein, SS Williams, SB Horwitz
Proceedings of the National Academy of Sciences 85 (11), 3762-3766, 1988
1261988
General organization of protein in HeLa 40S nuclear ribonucleoprotein particles.
L Lothstein, HP Arenstorf, SY Chung, BW Walker, JC Wooley, ...
The Journal of cell biology 100 (5), 1570-1581, 1985
1031985
Circumvention of P-GP MDR as a function of anthracycline lipophilicity and charge
TJ Lampidis, D Kolonias, T Podona, M Israel, AR Safa, L Lothstein, ...
Biochemistry 36 (9), 2679-2685, 1997
981997
Anthracycline drug targeting: cytoplasmic versus nuclear–a fork in the road
L Lothstein, M Israel, TW Sweatman
Drug Resistance Updates 4 (3), 169-177, 2001
912001
The composition and general topology of RNA and protein in monomer 40 S ribonucleoprotein particles
WM LeStourgeon, L Lothstein, BW Walker, AL Beyer
Nuclear Particles: The Cell Nucleus, Vol. 9 9, 49, 2013
61*2013
THE COMPOSITION AND GENERAL TOPOLOGY OF RNA AND PROTEIN IN MONOMER 40S RIBONUCLEOPROTEIN-PARTICLES
WM LESTOURGEON, L LOTHSTEIN, BW WALKER, AL BEYER
BIOLOGIE CELLULAIRE 39 (3), A51-A51, 1980
611980
Phosphorylation of mitochondrial phospholipid scramblase 3 by protein kinase C‐δ induces its activation and facilitates mitochondrial targeting of tBid
Y He, J Liu, D Grossman, D Durrant, T Sweatman, L Lothstein, RF Epand, ...
Journal of cellular biochemistry 101 (5), 1210-1221, 2007
602007
The release of 40S hnRNP particles by brief digestion of HeLa nuclei with micrococcal nuclease
BW Walker, L Lothstein, CL Baker, WM LeStourgeon
Nucleic acids research 8 (16), 3639-3658, 1980
511980
The structure of chromatin containing DNA complementary to 19 S and 26 S ribosomal RNA in active and inactive stages of Physarum polycephalum
EM Johnson, HR Matthews, VC Littau, L Lothstein, EM Bradbury, ...
Archives of biochemistry and biophysics 191 (2), 537-550, 1978
501978
Alternate overexpression of two P-glycoprotein [corrected] genes is associated with changes in multidrug resistance in a J774. 2 cell line.
L Lothstein, SI Hsu, SB Horwitz, LM Greenberger
Journal of Biological Chemistry 264 (27), 16054-16058, 1989
481989
Interferon-resistant Daudi cell line with a Stat2 defect is resistant to apoptosis induced by chemotherapeutic agents
Z Du, M Fan, JG Kim, D Eckerle, L Lothstein, L Wei, LM Pfeffer
Journal of Biological Chemistry 284 (41), 27808-27815, 2009
352009
Involvement of PKC delta (PKCδ) in the resistance against different doxorubicin analogs
MID Bessone, DE Berardi, PB Campodónico, LB Todaro, L Lothstein, ...
Breast cancer research and treatment 126 (3), 577-587, 2011
332011
Novel Extranuclear-targeted Anthracyclines Override the Antiapoptotic Functions of Bcl-2 and Target Protein Kinase C Pathways to Induce Apoptosis 1 Supported in part by grants …
CM Barrett, FL Lewis, JB Roaten, TW Sweatman, M Israel, JL Cleveland, ...
Molecular cancer therapeutics 1 (7), 469-481, 2002
332002
Protection from doxorubicin-induced cardiomyopathy using the modified anthracycline N-benzyladriamycin-14-valerate (AD 198)
C Cai, L Lothstein, RR Morrison, PA Hofmann
Journal of Pharmacology and Experimental Therapeutics 335 (1), 223-230, 2010
312010
Expression of phenotypic traits following modulation of colchicine resistance in J774. 2 cells
L Lothstein, SB Horwitz
Journal of cellular physiology 127 (2), 253-260, 1986
311986
N-Benzyladriamycin-14-Valerate (AD198) Induces Apoptosis through Protein Kinase C-δ–Induced Phosphorylation of Phospholipid Scramblase 3
Y He, J Liu, D Durrant, HS Yang, T Sweatman, L Lothstein, RM Lee
Cancer research 65 (21), 10016-10023, 2005
302005
系统目前无法执行此操作,请稍后再试。
文章 1–20